N
NextBioMedical Co Ltd
KOSDAQ:389650
NextBioMedical Co Ltd
KOSDAQ:389650
Price:
79 300
KRW
-1.37%
Market Closed
Market Cap:
₩650.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
NextBioMedical Co Ltd
KOSDAQ:389650
|
KR |
|
MPH Health Care AG
XETRA:93M1
|
DE |
|
Boat Rocker Media Inc
TSX:BRMI
|
CA |
|
Aeon Financial Service Co Ltd
TSE:8570
|
JP |
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
IN |
|
L
|
LifeSemantics Corp
KOSDAQ:347700
|
KR |
|
Hansol Chemical Co Ltd
KRX:014680
|
KR |
|
Tianqi Lithium Corp
SZSE:002466
|
CN |
|
Sleep Number Corp
NASDAQ:SNBR
|
US |
Income Statement
Earnings Waterfall
NextBioMedical Co Ltd
NextBioMedical Co Ltd
Income Statement
NextBioMedical Co Ltd
NextBioMedical Co Ltd
Currency: KRW
| Jun-2025 | Sep-2025 | ||
|---|---|---|---|
| Revenue | |||
| Interest Expense |
349
|
422
|
|
| Revenue |
12 163
N/A
|
14 905
+23%
|
|
| Gross Profit | |||
| Cost of Revenue |
(4 221)
|
(4 736)
|
|
| Gross Profit |
7 942
N/A
|
10 168
+28%
|
|
| Operating Income | |||
| Operating Expenses |
(10 711)
|
(11 559)
|
|
| Selling, General & Administrative |
(5 277)
|
(4 317)
|
|
| Research & Development |
(5 381)
|
(7 172)
|
|
| Depreciation & Amortization |
(54)
|
(71)
|
|
| Operating Income |
(2 769)
N/A
|
(1 391)
+50%
|
|
| Pre-Tax Income | |||
| Interest Income Expense |
355
|
1 310
|
|
| Gain/Loss on Disposition of Assets |
10
|
0
|
|
| Total Other Income |
(111)
|
(37)
|
|
| Pre-Tax Income |
(2 516)
N/A
|
(118)
+95%
|
|
| Net Income | |||
| Tax Provision |
0
|
0
|
|
| Income from Continuing Operations |
(2 516)
|
(118)
|
|
| Net Income (Common) |
(2 516)
N/A
|
(118)
+95%
|
|
| EPS (Diluted) |
-310.03
N/A
|
-14.49
+95%
|
|
Switch to:
Switch to:
See Also
Discover More
